返回Google圖書搜尋

Drug Industry Antitrust Act

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly

其他書名	Hearings Before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Seventh Congress, First Session, Eighty-Seventh Congress, Second Session
出版	U.S. Government Printing Office, 1961
URL	http://books.google.com.hk/books?id=Duo-68RaBDEC&hl=&source=gbs_api
EBook	FULL_PUBLIC_DOMAIN

註釋Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.